Concizumab
Product Specifications
CAS Number
1312299-39-0
Target
Others, Factor Xa
Related Pathways
Others, Metabolism
Purity
0.95
Bioactivity
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site. Injections of Concizumab increase thrombin in blood, thereby preventing and treating hemophilia.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV811157 1.0 µg DNA
FLJ11151 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details NBP2-99263AF700 0.1 mL
Rabbit Polyclonal C1QB Antibody [Alexa Fluor 700]
Sign In for Pricing
View Details 
B-G-069-02 100 µL
Cholecystokinin-33 (CCK-33) (Human) - Biotin Labeled Purified IgG
Sign In for Pricing
View Details